Issue 23 of Multiple Myeloma Research Review.
Highlights include:
• Revised Myeloma Comorbidity index for multiple myeloma prognosis.
• Genetic basis for zoledronic-acid related osteonecrosis of the jaw.
• Front-line carfilzomib-containing regimens for multiple myeloma.
• Multiple myeloma prognoses predicted by immunoglobulin recovery post-SCT.